TrialReader


Nutritional Intervention for Constipation Symptoms in Patients With Parkinson's Disease

NCT07213856 — Not applicable, Recruiting, 54 participants, Hospital de Clinicas de Porto Alegre

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Nutritional Intervention for Constipation Symptoms in Patients With Parkinson's Disease: A Randomized Clinical Trial

RegistryNCT07213856, acronym NUTRI-GUT-PD
StatusRecruiting
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: single, treatment
Enrollment54 (Estimated)
SponsorHospital de Clinicas de Porto Alegre (Other)
ConditionsParkinsons Disease (PD), Constipation - Functional
InterventionsDietitian-Guided Nutritional Intervention (Behavioral)
Datesstart 2026-04-02, primary completion 2027-06-01 (estimated), completion 2029-08-01 (estimated), first posted 2025-10-09, last updated 2026-06-16
Locations1 site in Brazil

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Parkinsons Disease (PD) All trials for Constipation - Functional All trials of Dietitian-Guided Nutritional Intervention

-Summary

The goal of this clinical trial is to evaluate whether a dietitian-guided nutritional intervention can improve constipation symptoms in people with Parkinson's disease (PD). The main questions it aims to answer are:

* Can a dietitian-guided nutritional intervention increase the number of weekly bowel movements in individuals with PD and functional constipation?
* Can this intervention positively influence gut microbiota composition, dietary intake, and nutritional status?

Researchers will compare the intervention group to a control group that will receive general dietary guidance only after the study period, to see if the intervention leads to improvements in bowel function and related health outcomes.

Participants will:

* Follow a diet plan developed by a dietitian, based on dietary reference intakes and tailored to the needs of individuals with PD and constipation
* Participate in follow-up sessions with the dietitian for 3 months
* Complete assessments at baseline, midpoint, and end of the intervention to evaluate bowel function, constipation symptoms, gut microbiota, nutritional status, and diet quality

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Nutritional Intervention GroupExperimentalBehavioral: Dietitian-Guided Nutritional InterventionParticipants will receive a tailored diet plan made by a registered dietitian, with follow-ups for 3 months. The plan is based on Dietary Reference Intakes and adapted to Parkinson's disease and constipation management guidelines.
Control GroupNo interventionParticipants will not receive individualized nutritional support during the study period. They will receive the dietary guidance only after the end of the study (3 months).
  • Dietitian-Guided Nutritional Intervention (Behavioral), also known as Diet plan: Participants receive a diet plan and nutritional counseling provided by a registered dietitian, based on a standardized protocol aligned with the Dietary Reference Intakes (DRIs) and adapted for the management of Parkinson's disease and constipation. The intervention includes follow-ups with the dietitian over a 3-month period.

+Outcome measures

Primary outcomes

  • Change in weekly bowel movement frequency [Baseline and 90 days]: Mean change in the number of spontaneous bowel movements per week from baseline to 12 weeks, based on participant-reported bowel diaries.

Secondary outcomes

  • Change in relative abundance of gut microbial taxa [Baseline and 90 days]: Change in the relative abundance of selected bacterial genera associated with constipation and Parkinson's disease, measured by 16S rRNA sequencing of stool samples.

Other outcomes

  • Change in dietary intake [Baseline, 45 days and 90 days]: Variation in intake of macronutrients and fiber, assessed through 24h food records.

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Adults with a previous diagnosis of Parkinson's disease
* On a stable dose of levodopa for at least 3 months
* Diagnosis of Functional Constipation by the Rome IV protocol

Exclusion Criteria:

* Diagnosis of atypical or secondary parkinsonism
* Hoehn and Yahr stage greater than 2
* Presence of severe neurological or psychiatric disorders that impair the ability to participate in study procedures
* Previous diagnosis of dementia
* Presence of comorbidities such as active cancer, chronic obstructive pulmonary disease (COPD), heart failure, and/or chronic kidney disease
* History of gastrointestinal cancers, inflammatory bowel diseases, or surgeries involving the gastrointestinal tract
* Constipation secondary to clinical conditions such as hypothyroidism or diabetes mellitus
* Use of opioids
* Use of probiotics or antibiotics in the past 8 weeks
* Continuous use of laxatives in the past 8 weeks
* Presence of severe dysphagia according to the Functional Oral Intake Scale (FOIS)
* Individuals receiving enteral or parenteral nutrition
* Individuals under nutritional follow-up in the past 3 months

+Locations (1)

FacilityCityCountryStatus
Hospital de ClĂ­nicas de Porto Alegre (HCPA)Porto Alegre, Rio Grande do SulBrazilRecruiting

+Publications

  • National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Food and Nutrition Board; Committee on the Dietary Reference Intakes for Energy. Dietary Reference Intakes for Energy. Washington (DC): National Academies Press (US); 2023 Jan 17. Available from http://www.ncbi.nlm.nih.gov/books/NBK588659/ PMID 36693139
  • Barichella M, Cereda E, Cassani E, Pinelli G, Iorio L, Ferri V, Privitera G, Pasqua M, Valentino A, Monajemi F, Caronni S, Lignola C, Pusani C, Bolliri C, Faierman SA, Lubisco A, Frazzitta G, Petroni ML, Pezzoli G. Dietary habits and neurological features of Parkinson's disease patients: Implications for practice. Clin Nutr. 2017 Aug;36(4):1054-1061. doi: 10.1016/j.clnu.2016.06.020. Epub 2016 Jul 5. PMID 27406858
  • Drossman DA, Hasler WL. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 2016 May;150(6):1257-61. doi: 10.1053/j.gastro.2016.03.035. No abstract available. PMID 27147121
  • Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015 Oct;30(12):1591-601. doi: 10.1002/mds.26424. PMID 26474316
  • Results publication: Brendler JH, da Silva KY, Dall'Alba V, Martins AF, Teixeira-Dos-Santos D, Schuh AFS, Olchik MR. Dietitian-led intervention to manage constipation in Parkinson's disease: Study protocol for a parallel-group randomized controlled trial (NUTRI-GUT-PD). PLoS One. 2026 Jul 27;21(7):e0354608. doi: 10.1371/journal.pone.0354608. eCollection 2026. PMID 42507749

+Investigators

My Notes